• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Vaccine X . Effects of different HA and NA gene combinations on the growth characteristics of the H3N8 influenza candidate vaccine virus

tetano

Editor, Senior Moderator
Vaccine X


. 2024 Jul 18:19:100531.
doi: 10.1016/j.jvacx.2024.100531. eCollection 2024 Aug. Effects of different HA and NA gene combinations on the growth characteristics of the H3N8 influenza candidate vaccine virus

Liqi Liu[SUP] 1 [/SUP], Zi Li[SUP] 1 [/SUP], Jia Liu[SUP] 1 [/SUP], Xiyan Li[SUP] 1 [/SUP], Jianfang Zhou[SUP] 1 [/SUP], Ning Xiao[SUP] 1 [/SUP], Lei Yang[SUP] 1 [/SUP], Dayan Wang[SUP] 1 [/SUP]



Affiliations
Abstract

Since 2022, three human cases of a novel H3N8 avian influenza virus infection have been reported in three provinces in China. Specific vaccines are important means of preparing for the potential influenza pandemic. Thus, H3N8 viruses [A/Henan/cnic410/2022 (HN410) and A/Changsha/1000/2022(CS1000)] were isolated from the infected patients as prototype viruses to develop candidate vaccine viruses (CVVs) using the reverse genetics (RG) technology. Five reassortant viruses with different HA and NA combinations were constructed based on the two viruses to get a high-yield and safe CVV. The results showed that all viruses had similar antigenicity but different growth characteristics. Reassortant viruses carrying NA from CS1000 exhibited better growth ability and NA enzyme activity than the ones carrying HN410 NA. Furthermore, the NA gene of CS1000 had one more potential N-glycosylation site at position 46 compared with HN410. The substitution of position 46 showed that adding or removing N-glycosylation sites to different reassortant viruses had different effects on growth ability. A reassortant virus carrying HN410 HA and CS1000 NA with high growth ability was selected as a CVV, which met the requirements for a CVV. These data suggest that different surface gene combinations and the presence or absence of potential N-glycosylation sites on position 46 in the NA gene affect the growth characteristics of H3N8 CVVs.

Keywords: Candidate vaccine virus; Growth characteristics; H3N8 avian influenza virus; N-glycosylation site; NA enzyme activity.

 
Back
Top Bottom